Syngene International is a Contract Service company operating in the pharmaceutical industry.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene’s more than 6000 scientists offer both skills and the capacity to deliver great science, robust data management, and I.P. security and quality manufacturing at speed to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development, and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.
Company type
Contract Service
Products and services
Biopharmaceuticals, Custom Manufacturing, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services, Pharmaceutical Machinery & Technology
Markets
Oceania, North America (USA, Canada), Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Visit the Syngene International Website
Connect with Syngene International on Facebook
Connect with Syngene International on LinkedIn
Address
Syngene International, Biocon Park , Plot 2&3,, Bommasandra Industrial Estate – Phase-IV, Bangalore, India, 560 099
